A phase II study of sequential methotrex
β
L. Panasci; J. Ford; R. Margolese
π
Article
π
1985
π
Springer
π
English
β 242 KB
Twenty-nine patients with advanced colorectal cancer were treated with methotrexate (MTX) 200 mg/m2 followed 1 h later by fluorouracil (FU) (1000 mg/m2) and 24 h later by oral leucovorin 20 mg every 6 h for six doses. The cycle was repeated every 2 weeks. Among the 25 evaluable patients there were 2